Clinical Trials List
2020-08-16 - 2024-12-31
Phase III
Terminated7
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Yu-Jui Huang Division of Psychiatry
- 鍾國軒 Division of Psychiatry
- HSIN-CHIEN LEE 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- HUNG-KUANG SU Division of Psychiatry
- 徐勝駿 Division of Psychiatry
- 謝明憲 無
- 陳宜明 Division of Psychiatry
- YI-TING LIN Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 鄭智銘 Division of Psychiatry
- 胡力允 Division of Psychiatry
- Cheng-Ta Li Division of Psychiatry
- Ya-Mei Bai Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
25 participants
-
Global
550 participants
